Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Adult outcomes of patients with juvenile idiopathic arthritis.

Minden K.

Horm Res. 2009 Nov;72 Suppl 1:20-5. doi: 10.1159/000229759. Epub 2009 Nov 27.

PMID:
19940491
2.

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.

Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chédeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, Rosenberg AM, Cameron B, Johnson N, Dorval J, Scuccimarri R, Campillo S, Petty RE, Duffy KN, Boire G, Haddad E, Houghton K, Laxer R, Turvey SE, Miettunen P, Gross K, Guzman J, Benseler S, Feldman BM, Espinosa V, Yeung RS, Tucker L.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):527-36. doi: 10.1002/acr.20044.

3.

Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.

Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M; Nordic Study Group of Pediatric Rheumatology.

Arthritis Rheum. 2011 Sep;63(9):2809-18. doi: 10.1002/art.30426.

4.

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.

Arthritis Rheum. 2003 Apr;48(4):1093-101.

5.

Effects of growth hormone treatment on growth in children with juvenile idiopathic arthritis.

Simon D, Bechtold S.

Horm Res. 2009 Nov;72 Suppl 1:55-9. doi: 10.1159/000229765. Epub 2009 Nov 27. Review.

PMID:
19940497
6.

Update on treatment of arthritis in children: new treatments, new goals.

Lovell DJ.

Bull NYU Hosp Jt Dis. 2006;64(1-2):72-6. Review.

7.

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.

Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2009 May;68(5):635-41. doi: 10.1136/ard.2007.087411. Epub 2008 Apr 15.

PMID:
18413443
8.

[Juvenile idiopathic arthritis].

Herlin T.

Ugeskr Laeger. 2002 Aug 19;164(34):3941-6. Review. Danish.

PMID:
12212473
9.

Natural history of growth and body composition in juvenile idiopathic arthritis.

Bechtold S, Roth J.

Horm Res. 2009 Nov;72 Suppl 1:13-9. doi: 10.1159/000229758. Epub 2009 Nov 27. Review.

PMID:
19940490
10.

Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.

Simon D, Fernando C, Czernichow P, Prieur AM.

J Rheumatol. 2002 Jun;29(6):1296-300.

PMID:
12064849
11.

Juvenile idiopathic arthritis--current and future therapies.

Kahn P.

Bull NYU Hosp Jt Dis. 2009;67(3):291-302. Review.

PMID:
19852753
12.

Effect of inflammatory activity and glucocorticoid [corrected] use on nutritional variables in patients with juvenile idiopathic arthritis.

Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM.

J Rheumatol. 2006 Mar;33(3):601-8. Erratum in: J Rheumatol. 2006 Apr;33(4):829.

PMID:
16511929
13.

A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.

Thornton J, Ashcroft D, O'Neill T, Elliott R, Adams J, Roberts C, Rooney M, Symmons D.

Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. Review.

14.

Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.

Bechtold S, Simon D.

Rheumatol Int. 2014 Nov;34(11):1483-8. doi: 10.1007/s00296-014-3022-2. Epub 2014 Apr 24. Review.

PMID:
24760485
15.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347. Epub 2011 May 28.

PMID:
21623000
16.
17.

Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis.

Sarma PK, Misra R, Aggarwal A.

Clin Rheumatol. 2008 Oct;27(10):1261-5. doi: 10.1007/s10067-008-0901-5. Epub 2008 May 24.

PMID:
18500441
18.

New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.

Beresford MW, Baildam EM.

Arch Dis Child Educ Pract Ed. 2009 Oct;94(5):144-50. doi: 10.1136/adc.2008.144576. Review.

PMID:
19770494
19.

Update on biologicals for treatment of juvenile idiopathic arthritis.

Horneff G.

Expert Opin Biol Ther. 2013 Mar;13(3):361-76. doi: 10.1517/14712598.2013.735657. Epub 2013 Jan 5. Review.

PMID:
23289865
20.

Long-term outcome in patients with juvenile idiopathic arthritis.

Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A.

Arthritis Rheum. 2002 Sep;46(9):2392-401.

Supplemental Content

Support Center